QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

Subsequent Events

9 Months Ended

Sep. 30, 2019

NOTE 10 – SUBSEQUENT EVENTS

On November 5, 2019, the Company filed a preliminary Form 14A Proxy Statement with the SEC to hold a special meeting of the stockholders to vote on the following matters:

	1)	Increase the number of authorized common shares from 100,000,000 to 300,000,000;
	2)	Authorize the Board of Directors to affect a stock split in the ratio of 1:2 to 1:25 in their discretion;
	3)	Adopt the Company’s Amended Omnibus Equity Plan; and
	4)	To authorize an adjournment of the meeting if necessary.

The special meeting of the stockholders is expected to be held in December 2019.